The (2R,5S)-trans-and (2S,5S
Histaminergic neurotransmission in rodent brain is regulated by constitutively active histamine H 3 receptor (H 3 R) 1) in vitro as well as in vivo.
2) H 3 R is a presynaptic autoreceptor that is mainly localized in the central nervous system (CNS) and acts to modulate the biosynthesis and release of histamine from histaminergic neurons.
3) H 3 R is also a heteroreceptor that modulates the release of a number of neurotransmitters, 4) e.g., dopaminergic 5) and serotonergic 6) systems. H 3 -antagonists increase central histamine levels and may therefore be useful for the treatment of a variety of CNS disorders, including eating disorder, 7) schizophrenia, 8) narcolepsy, 9) epilepsy and cognitive disorders, and attentiondeficit hyperactivity disorder (ADHD). 10) However, the precise therapeutic potential of H 3 -antagoanists remains unknown to this day. After the discovery of the fourth subtype of histamine receptor designated as H 4 receptor (H 4 R) in 2000, H 3 -antagonists and agonists were found to bind not only to H 3 R but also to H 4 R. [11] [12] [13] In order to investigate the physiological and pathophysiological roles of H 3 R and H 4 R, the development of more selective H 3 R ligands is indispensable.
In studies directed toward the preparation of new H 3 ligands, the cyclopropane ring has been often used as a conformationally restricted spacer located between an imidazole and an amino function, which are essential for the activation of H 3 R. [14] [15] [16] Indeed, the H 3 -antagonist GT-2331 (cipralisant, Perceptin) 17, 18) has entered Phase II clinical trials for the treatment of ADHD, and Shuto and co-workers 19) very recently developed potent H 3 antagonists (CAIC) that have the cyclopropane structure (Fig. 1) . The introduction of a hydrophobic group to lead compounds also plays a crucial role in the functional inversion of an agonist into the corresponding antagonist. A large number of compounds that were prepared in the course of the search for novel H 3 -antagonists have a hydrophobic group on the histamine-related structure, some examples of which are shown in Fig. 1 . [20] [21] [22] The hydrophobic moiety is usually either an aromatic or a saturated ring system, but it can also be a carbon chain.
We previously examined the effect of four stereoisomers of 4(5)-(5-aminomethyl-tetrahydrofuran-2-yl)imidazole on H 3 R in rat brain using in vivo microdialysis. Among them, only the (ϩ)-(2R,5R)-isomer (imifuramine) [23] [24] [25] exhibited H 3 -agonistic activity that approximately equaled that of immepip (Fig. 2) . 26) The tetrahydrofuran (THF) ring of imifuramine may assume flexible conformations by characteristic pseudo-rotations of the five-membered ring. On the other hand, immepip 27) and thioperamide, 3) which are well known as the nonchiral prototypes of H 3 R agonists and antagonists, adopt a piperidine spacer having stable chair conformation, and the N-function in the piperidine is located four atoms away from the imidazole. With these results and the strategy described previously for the synthesis of new H 3 -ligands in mind, we reasoned that as molecular templates, 4(5)-(5-aminotetrahydropyran-2-yl)imidazoles (ATPIs, 1) might be constrained by a six-membered chair conformation positioned between an imidazole and an amino group, providing four chiral stereoisomers 1a-d, as shown in Fig. 2 28) Although the optical integrity of 2 were described in the literature, 28) the reaction required 10 days (d) at room temperature (rt) to obtain 2. We actually obtained 2 in only 42% yield over 13 d in aqueous K 2 CO 3 at 40°C. Microwave (MW) irradiation of organic reactions is known to accelerate a variety of synthetic transformations via time-and energy-saving protocols. 29) When we attempted the tribenzylation of L-glutamine under MW irradiation conditions [DMF-H 2 O (1 : 1), 80°C], the reaction time was remarkably shortened to 1 h and the yield of 2 was considerably improved to 69%, making this compound readily available (see Experimental section). Chemoselective reduction (91%) of the ester group of 2 by LiAlH 4 at 0°C to form hydroxy amide 3, followed by refluxing of 3 in toluene, afforded (5S)-5-dibenzylamino-THP-2-one 4 (98%). Reduction of 4 with DIBAL, followed by addition of the lithium salt of bis-protected imidazole 5 30) to the resulting lactol, gave diol 6 (92%). 31) Hydrolysis of 6 in refluxing 1.5 N HCl afforded diol 7 having an unsubstituted imidazole in 93% yield.
We previously reported an efficient method for the formation of ribofuranosyl C-nucleosides or THFs with a fivemembered ring via a diazafulvene intermediate (like 8), which involved intramolecular cyclodehydration of the corresponding diols using N,N,NЈ,NЈ-tetramethylazodicarboxamide (TMAD) 32) and Bu 3 P. 31 ) Therefore, we first attempted treatment of 7 with TMAD (1.5 eq) and Bu 3 P (1.5 eq) at rt in benzene for 17 h, followed by tert-butoxycarbonylation to facilitate isolation, but N im -Boc-THP intermediate 10 was produced in only 7% yield (Table 1 , entry 1). Use of 3 equivalents each of TMAD and Bu 3 P under benzene reflux somewhat improved the yield to 43% (entry 2). In contrast, the reaction of diol 6 containing bis-protected imidazole with TMAD-Bu 3 P did not proceed at all. These results indicated that cyclization to a six-membered ring using the TMADBu 3 P method was more difficult than that to the previous five-membered rings. Alternatively, reagents that activate one hydroxy group to promote the cyclization have been used, such as Burgess reagent, 33) Hendrickson reagent, 34) and Martin's sulfurane. 35) However, the first two reagents did not work at all, and Martin's sulfurane resulted in an inseparable mixture of 10 and diphenylsulfoxide. In an effort to improve the reaction, we turned our attention to the net loss of water using an azeotropic mixture. When diol 7 was refluxed in benzene or toluene in the presence of TsOH (0.1 eq) using a Dean-Stark water separator, the cyclo-dehydration reaction proceeded effectively to afford 10 in 61% or 69% yield (entries 3, 4). The hydrolysis of thus obtained 10 with 1.5 N aqueous HCl, followed by debenzylation afforded 3 : 1 diastereomixture 1, which was separated easily by silica gel column chromatography to obtain novel chiral (ϩ)-(2R,5S)-ATPI (1a, 75%) and (Ϫ)-(2S,5S)-ATPI (1b, 25%) in a trans or cis relationship. Their enantiomeric units, (Ϫ)-(2S,5R)-trans-and (ϩ)-(2R,5R)-cis-ATPIs (1c, 1d), were also obtained from D-glutamine with the present synthetic methodology (Chart 1, Eq. 1).
The trans-or cis-stereochemistry of 1a and 1b was assigned by detailed observations of 1 H-NMR spectra, as illustrated in Fig. 3 . Trans-isomer 1a showed 1 H-1 H NOESY interactions among H-2 ax -H-4 ax , H-2 ax -H-6 ax , and H-3 ax -H-5 ax . In particular, the H-5 resonance at dϭ2.80 ppm for 1a appeared as a triplet of triplets with J 5-6ax ϭJ 5-4ax ϭ12.4 Hz and J 5-6eq ϭJ 5-4eq ϭ3.4 Hz. These coupling constants confirmed that H-2 and H-5 occupied axial positions in a chair conformation with the imidazole base and the amino group in equatorial orientations. On the other hand, for 1b, NOESY data and coupling constant (H-5 eq : d 2.92, broad singlet) indicated cis-stereochemistry with the imidazole moiety and the amino group in equatorial and axial orientations, respectively.
Stereoisomers 1a-d of synthesized ATPI were employed as base compounds in this study. Each isomer was first con- 
Chart 2. Synthesis of (2S,5R)-ATPI Derivatives and (2S,5R)-cyclohexylthioureas 14a and 14b (entries 17, 18), and (2S,5R)-4-chlorophenylurea 15 (entry 19).
In Vivo Microdialysis Experiments of ATPIs Pharmacological activities of the four stereoisomers of amino compounds 1a-d, cyanoguanidines 11a-d, isopropylamines 12a-d, and 3,3-dimethylbutylamines 13a-d were first tested by in vivo brain microdialysis to examine whether the stereoisomers had any effects on the release of histamine in rat hypothalamus.
In vivo microdialysis is widely used to measure the extracellular levels of many substances in the brain, 36) and is suitable for the determination of neurotransmitter dynamics in vivo. A microdialysis probe is implanted into the anterior hypothalamic area (AHy) of rats anesthetized with urethane, as illustrated in Fig. 4a . 37) In all cases, the probe is perfused with artificial cerebrospinal fluid (CSF) containing ATPI derivatives at the concentration of 10 mM, and endogenous histamine in AHy is recovered from the surrounding extracellu- The histaminergic system has its cell bodies in the tuberomammillary nucleus (TM) and projects to several brain regions. b) Principle of the microdialysis probe. It can be used to recover and administer substances in living tissue.
Fig. 5. Effects of 13c on in Vivo Histamine Release in Rat Hypothalamus as Measured by Microdialysis
The compound (10 mM) was infused into the hypothalamus via the microdialysis probe. The average value in the first three samples was taken as basal release. Results are expressed as percentages of basal release and are means (Ϯ) S.E.M. * Significant ( * p<0.05, * * p<0.01) difference between groups was determined by ANOVA with Newman-Keuls proceudre; a) number of animals. lar fluid through the membrane at the probe tip (Fig. 4b) . The fractions are collected every 20 min and histamine analysis is carried out by an HPLC-fluorometric method.
38 ) The results of evaluation are summarized in Table 2 .
Relationship between ATPI Configuration and Neuronal Histamine Release in Rat Brain None of isomers 1a-d and 11a-d had any effects on histamine release ( Table 2 , entries 1-8). In the case of N-isopropylamines 12a-d (entries 9-12), only 2S,5R-isomer 12c increased histamine release by approximately 120-130% compared with the basal level (entry 11). In 3,3-dimethylbutylamines 13a-d that contained a bulky t-butyl group at the end of the alkyl chain, (2S,5R)-isomer 13c showed relatively high histamine release (180-190%; run 15) compared with the basal level, as illustrated in Fig. 5 , while other stereoisomers, (2R,5S)-isomer 13a, (2S,5S)-isomer 13b, and (2R,5R)-isomer 13d had no effect on histamine release (Table 2 , entries 13, 14, 16) .
In addition, cyclohexylthiourea 14b having the 2S,5R-configuration showed a slight effect on histamine release (120-130%), while enantiomer 14a had no effect on the release (entries 17, 18). (2S,5R)-4-Chlorophenylurea 15 moderately increased histamine release by 140-150% compared with the basal level (entry 19). The results of these in vivo microdialysis experiments indicated that only the 2S,5R-configuration of ATPIs induced the release of histamine in rat brain.
Effect of 13c and Immepip on in Vivo Histamine Release The positive findings for (2S,5R)-N-3,3-dimethylbutylamine 13c motivated us to further investigate the effect of coperfusing 13c and immepip (Fig. 2) , 27) a potent and selective H 3 -agonist that has been used in many studies, on in vivo histamine release (Fig. 6 ). The administration of immepip (0.1 mM) alone decreased histamine release to approximately 30% of the basal level, and this effect was apparently reversed by coperfusion of 13c (10 mM), which increased histamine release to approximately 170% of the basal level. These findings support the idea that the antagonistic activity of 13c takes place via an H 3 R.
Influence of (2S,5R)-N-Alkyl ATPIs on Histamine Release in AHy The present H 3 -antagonists have three common and essential structural features: the key imidazole head group, a spacer, and a hydrophobic tail group, as shown in Fig. 1 . From the results of Table 2 , the 2S,5R-configuration of ATPI derivatives was confirmed to be essential for histamine release. Then, our attention was directed to the optimization of the hydrophobic tail group and the N-alkyl chain length. Ten (2S,5R)-N-alkyl-ATPIs 16-25 were further prepared by reductive amination of 1c according to Chart 2, Eq. 2. The yields of the novel N-alkyl compounds from 1c and the results of their microdialysis are summarized in Tables 3  and 4 .
Shortening the spacer from an ethylene (13c) to a methylene moiety (16) reduced somewhat histamine release (130-160%) compared to that of 13c (Table 4 , entry 2). However, cyclohexyl analogue 18, which has a methylene spacer, gave a high histamine release of 180-200%, the highest in this study (Table 4 , entry 4 and Fig. 7) . Extended homologues 19, 20, and 21, which have NH and cyclohexane moieties tethered by a long carbon spacer (an ethylene, a propylene, and a butylene moiety, respectively), reduced histamine release (120-160%), as shown in Fig. 7 (Table 4, entries 4-7) , while cyclohexyl amine 17, in which the N atom is directly attached to the cyclohexane ring, was inactive (Table 4 , entry 3). Accordingly, among the cyclohexane homologues, the methylene spacer of 18 was optimal for histamine release. In contrast, none of the four hydrophobic moieties: 3-cyclohexenyl, cyclopropyl, cyclopentyl, and 4-chlorophenyl groups ( methylene spacer. The results suggested that the moieties that are almost to flat or planar, were unsuitable as the hydrophobic tail group of ATPIs. To clarify whether 18 is an H 3 -antagonist, we again examined its antagonistic activity against immepip 27) (Fig. 8) . The administration of immepip (0.01 mM) to the perfusion fluid decreased histamine release to approximately 60% of the basal level. Co-infusion of 18 (10 mM) fully antagonized this effect and increased histamine release to approximately 160% of the basal level. This indicated that the H 3 -antagonistic activity of 18 was mediated by H 3 R.
Conclusion
Novel ATPI isomers 1a-d were synthesized from L-or Dglutamine (Chart 1). Then, five types of N-substituted derivatives based on 1a-d were prepared to examine their influence on histamine release in rat brain through in vivo brain microdialysis experiments (Chart 2). The results are summarized as follows: 1) Basal amino isomers 1a-d are inactive, although some of the N-substituted derivatives enhance histamine release (Table 2) . 2) The 2S,5R-configuration of the THP ring is the bioactive configuration for histamine release. (Figs. 6,  8 ). 5) The carbon chain length (n) between NH and a hydrophobic tail group of nϭ1 or 2 is appropriate, and a bulky substituent (tert-butyl or cyclohexyl) is preferred to a planelike substituent as the hydrophobic tail group (Table 4 , entries 8-11). 6) Previous studies have shown that imifuramine derivatives having flexible five-membered THF structures generally exhibit H 3 -agonistic activities. 23, 25) In contrast, this study has shown that six-membered ATPIs having stable chair spacers exhibit only H 3 -antagonistic activities. Armed with the findings of H 3 -antagonists 13c and 18, the synthesis of related ATPI derivatives and studies of their pharmacological effects are in progress in our laboratories.
Experimental
General Melting points were determined on a hot-stage apparatus and were uncorrected. Optical rotation measurements were recorded with a JASCO DIP-1000 digital polarimeter. IR spectra were recorded on a Shimadzu IR-435 spectrometer.
1 H-and 13 C-NMR spectra were measured with tetramethylsilane as internal standard on Varian Gemini-200, Varian Mercury-300, and Varian UNITY INOVA-500 spectrometers. Reactions with air-and moisture-sensitive compounds were carried out under argon atmosphere. Unless otherwise noted, all extracts were dried over Na 2 SO 4 and the solvent was removed in a rotary evaporator under reduced pressure. BW-127ZH (Fuji Silysia Chemical Ltd.) and Chromatorex NH-DM 1020 [(NHsilica gel), Fuji Silysia Chemical Ltd.] were used for column chromatography. Dehydrated THF was purchased from Wako Pure Chemical Industries, Ltd. TLC was performed on pre-coated TLC plates with 60F 254 (silica gel, Merck). MW-assisted reaction of the first step was performed in a Milestone MicroSYNTH multimodal reactor with thermal control. 28) To a solution of L-glutamine (10.2 g, 69.9 mmol) and K 2 CO 3 (47.7 g, 343 mmol) in H 2 O (400 ml) was added BnBr (34 ml, 280 mmol). The mixture was well stirred with a mechanical stirrer for 13 d while maintaining the temperature at 40°C. After the reaction, the reaction mixture was extracted twice with ethyl acetate and dried. The organic layer was evaporated to give a residue that was purified by silica gel (BW-127ZH) column chromatography [Rf (50% ethyl acetate/hexane); 0.19]. Elution with 20 to 100% ethyl acetate afforded 2 (12.24 g, 42%) as a pale yellow oil (Gmeiner and co-worker 28) obtained 2 in 46% after stirring 10 d at rt).
(2S)-Benzyl 4-Carbamoyl-2-dibenzylaminobutyrate (2). Method A (Gmeiner's Procedure)
Method B In a 30 ml Teflon MW reaction vessel, K 2 CO 3 (3.38 g, 24.5 mmol) in H 2 O (8 ml) was added to a solution of L-glutamine (730 mg, 5 mmol) in DMF (10 ml). Then, BnBr (2.4 ml, 20 mmol) was added and the vessel was sealed and heated in the Milestone MicroSYNTH MW reactor to 80°C over a 10 min period. The reaction was held at this temperature for 50 min and was allowed to cool thereafter. The contents were diluted with H 2 O and ethyl acetate. The organic layer was separated, dried, and evaporated to give a residue that was then subjected to chromatography (BW-127ZH). Elution with 20 to 80% ethyl acetate/hexane afforded 2 (1.44 g, 69%) as a pale yellow oil. To a suspension of lithium aluminum hydride (2.23 g, 58.6 mmol) in ether (100 ml) was added dropwise a solution of 2 (12.18 g, 29.3 mmol) in ether (120 ml) at 0°C, and the mixture was stirred for 40 min at the same temperature. Then, water (10 ml), 15% aqueous sodium hydroxide (10 ml), and water (10 ml) were successively added to the reaction mixture. The resultant mixture was dried over anhydrous magnesium sulfate, filtered through Celite, and evaporated. The residue was purified by silica gel (BW-127ZH) column chromatography (10% methanol/ethyl acetate) to afford 3 (8.30 g, 91%) as a pale yellow oil. 
2-tert-Butyldimethylsilyl-5-[(1RS,4S)-4-dibenzylamino-1,5-dihydroxypentyl]imidazole-N,N-dimethylsulfonamide (6)
To a solution of 4 (6.67 g, 22.6 mmol) in dry toluene (120 ml) at Ϫ70°C was added dropwise a 1 M solution of DIBAL in toluene (45.2 ml, 45.2 mmol) over 15 min. After stirring for 50 min at Ϫ70°C, the reaction mixture was quenched with methanol (40 ml) and further stirred for 30 min at rt. Saturated sodium bicarbonate (40 ml) solution was added and the reaction mixture was stirred for another 10 min. After anhydrous magnesium sulfate was added to the resulting suspension, the reaction mixture was stirred for 30 min, filtered through a Celite pad, and washed with ethyl acetate. The filtrate was evaporated to give a crude oil (5-dibenzylaminotetrapyran-2-ol). Alternatively, a solution of 5 (19.6 g, 67.8 mmol) in THF (66 ml) was cooled to Ϫ40°C, and 1.6 M BuLi-hexane (42 ml, 67.8 mmol) was added dropwise over 15 min to precipitate white lithium salt of 5. The resulting suspension was stirred for 15 min and cooled to Ϫ30°C. Then, a toluene solution (45 ml) of 5-dibenzylaminotetrapyran-2-ol prepared above was added slowly over 20 min at the same temperature, and the whole mixture was stirred for 5 min. The dry ice bath was removed and the reaction mixture was stirred at rt to dissolve the salts. After 15 h, a small amount of water was added to the mixture and the solvent was evaporated to give a residue that was extracted twice with ethyl acetate. The extract was washed with water and brine, dried, and evaporated to give a crude oil, which was purified by column chromatography (BW-127ZH, 50% ethyl acetate/hexane) to give 6 (12.12 g, 92%) as amorphous powder. 
4(5)-[(1RS,4S)-4-Dibenzylamino-1,5-dihydroxypentyl]imidazole (7)
To a THF solution (4 ml) of 6 (425 mg, 0.725 mmol) was added 1.5 N HCl (6 ml). The resulting mixture was refluxed for 3.5 h and neutralized by adding 30% NH 4 OH. The solvent was evaporated to give a residue that was extracted with ethyl acetate three times by the salting-out technique. The combined organic layer was dried and evaporated to give a crude oil that was subjected to column chromatography (BW-127ZH) using 20% methanol/ethyl acetate as eluent to give 7 (247 mg, 93%) as an amorphous product. 3 ) d: 1.18-1.30 (1H, m), 1.62-1.95 (3H, m), 2.61-2.79 (1H, m), 3.36-3.51 (4H, m), 3.63-3.75 (2H, m) 
H-NMR (CDCl

tert-Butyl-4-[(2RS,5S)-5-dibenzylaminotetrahydropyran-2-yl]imidazole-1-carboxylate (10)
The solution of 7 (130 mg, 0.356 mmol) in toluene (50 ml) containing a catalytic amount TsOH (6 mg, 0.036 mmol) was refluxed for 24 h as an azeotrope using a Dean-Stark water separator (molecular sieve 4A). After evaporation followed by neutralization by the addition of 30% NH 4 OH, the resulting mixture was extracted three times with chloroform, dried over anhydrous magnesium sulfate, and evaporated to give a crude oil of 9. A solution of Boc 2 O (155 mg, 0.71 mmol) in THF (1.5 ml) and then triethylamine (0.10 ml, 0.71 mmol) were added to the solution of 9 in THF (1.5 ml), and the resulting mixture was stirred at rt for 17 h. The solvent was evaporated. Chromatography on silica gel using 20% ethyl acetate/hexane as eluent gave 10 (109 mg, 69%) as a colorless oil. 08 mmol) in ethanol (40 ml) was added 1 N HCl (25 ml). The resulting mixture was stirred for 2 h at rt and the solvent was evaporated to give a residual oil. The oil was further diluted with ethanol and evaporated to remove water as an azeotrope. The operation was carried out again to give a pale yellow oil of 9 dihydrochloride. A solution of 9 dihydrochloride in EtOH (45 ml) was subsequently hydrogenated on 10% Pd-C (2.9 g) at an initial pressure of 3.0 kg/cm 2 for 19 h. The catalyst was removed by filtration through filter paper, and the filtrate was evaporated to give a residue (1 · 2HCl). The dihydrochloride was subjected to column chromatography (NH-silica gel) using CHCl 3 -MeOH-30%NH 4 OH (75 : 25 : 3). The eluents gave (ϩ)-1a (640 mg, 75%) and (Ϫ)-1b (208 mg, 25%) as colorless oils in succession.
( 12a-d, 13a, 13b, 13d, and 16-25 To a solution of 1c (46 mg, 0.275 mmol) and 3,3-dimethylbutylaldehyde (0.35 ml, 2.8 mmol) in 4 ml of absolute ethanol was added 3A molecular sieves (220 mg). After stirring the mixture at rt for 5 h, sodium borohydride (213 mg, 5.6 mmol) was added and the mixture was stirred for 23 h at rt. Then, the reaction mixture was diluted with ethanol (5 ml) and neutralized with 2 M acetic acid. The resulting insoluble material was filtered through Celite pad, and the filtrate was evaporated to give a residue that was purified by column chromatography using CHCl 3 -MeOH-30%NH 4 
